MedTrace Logo

Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)

NCT05439551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2023-10-24

No results posted yet for this study

Summary

This is a Prospective, multi-center, sample collection study enrolling pediatric and adult subjects presented to the ED/Urgent care, with symptoms consistent with acute bacterial or viral infection will be recruited according to eligibility criteria. The study is designed to measure the MeMed BV®️ score in whole blood and serum samples and demonstrate the equivalence between the two matrices. Patients will be managed according to the current standard of care per standard institutional procedures.

Conditions

  • Acute Infection

Interventions

DIAGNOSTIC_TEST

MeMed BV®

Patients Serum and Whole blood samples will be examined using the MeMed BV® test. Test results will have no impact on patient management.

Sponsors & Collaborators

  • MeMed Diagnostics Ltd.

    lead INDUSTRY

Eligibility

Min Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-11
Primary Completion
2022-11-13
Completion
2023-09-29
FDA Device
Yes

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05439551 on ClinicalTrials.gov